Literature DB >> 1540435

Are enzymatic tests good indicators of coronary reperfusion?

H A Bosker1, A van der Laarse, V M Cats, A V Bruschke.   

Abstract

OBJECTIVE: To assess the accuracy of four enzymatic tests, including early release rates of creatine kinase and alpha-hydroxybutyrate dehydrogenase, in assessing coronary reperfusion after thrombolytic therapy.
DESIGN: A prospective clinical trial identifying patients with a successful thrombolytic treatment. PATIENTS: Eighty nine patients with acute myocardial infarction were studied. Arteriography showed a closed infarct related artery in all of them. Reperfusion due to thrombolysis occurred in 74 patients and there was no reperfusion in 15 patients.
RESULTS: The 74 patients showing coronary reperfusion had a significantly shorter time to peak creatine kinase activity, higher early release rates for creatine kinase and alpha-hydroxybutyrate dehydrogenase, and a more rapid release of alpha-hydroxybutyrate dehydrogenase (ratio of cumulative release of alpha-hydroxybutyrate dehydrogenase during the first 24 hours to that 72 hours after infarction). All these differences were statistically significant (p less than 0.001). Optimum cut off levels were determined with decision level plots and the accuracy of the four enzymatic tests was calculated. Accuracy was low for all four tests (73%, 70%, 70%, and 82%).
CONCLUSION: None of the four enzymatic tests accurately predicted the perfusion state of the infarct related coronary artery after thrombolysis. These tests cannot be used reliably in routine clinical practice as non-angiographic markers of coronary reperfusion.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1540435      PMCID: PMC1024745          DOI: 10.1136/hrt.67.2.150

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  28 in total

1.  Characteristics and outcome of patients in whom reperfusion with intravenous tissue-type plasminogen activator fails: results of the Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) I trial.

Authors:  R M Califf; E J Topol; B S George; J M Boswick; K L Lee; D Stump; J Dillon; C Abbottsmith; R J Candela; D J Kereiakes
Journal:  Circulation       Date:  1988-05       Impact factor: 29.690

2.  The differential positive rate, a derivative of receiver operating characteristic curves useful in comparing tests and determining decision levels.

Authors:  C D Ward
Journal:  Clin Chem       Date:  1986-07       Impact factor: 8.327

3.  The wavefront phenomenon of ischemic cell death. 1. Myocardial infarct size vs duration of coronary occlusion in dogs.

Authors:  K A Reimer; J E Lowe; M M Rasmussen; R B Jennings
Journal:  Circulation       Date:  1977-11       Impact factor: 29.690

4.  Rapid enzyme release from acutely infarcted myocardium after early thrombolytic therapy: washout or reperfusion damage?

Authors:  A van der Laarse; E E van der Wall; R C van den Pol; F Vermeer; F W Verheugt; X H Krauss; F W Bär; W T Hermens; G M Willems; M L Simoons
Journal:  Am Heart J       Date:  1988-04       Impact factor: 4.749

5.  Peak creatine kinase as a measure of effectiveness of thrombolytic therapy in acute myocardial infarction.

Authors:  J M Gore; R Roberts; S P Ball; A Montero; R J Goldberg; J E Dalen
Journal:  Am J Cardiol       Date:  1987-06-01       Impact factor: 2.778

6.  Effects of early intracoronary streptokinase on infarct size estimated from cumulative enzyme release and on enzyme release rate: a randomized trial of 533 patients with acute myocardial infarction.

Authors:  A van der Laarse; F Vermeer; W T Hermens; G M Willems; K de Neef; M L Simoons; P W Serruys; J Res; F W Verheugt; X H Krauss
Journal:  Am Heart J       Date:  1986-10       Impact factor: 4.749

7.  Assessment of myocardial damage in patients with acute myocardial infarction by serial measurement of serum alpha-hydroxybutyrate dehydrogenase levels.

Authors:  A van der Laarse; W T Hermens; L Hollaar; M Jol; G M Willems; H E Lemmers; A H Liem; J H Souverijn; J H Oudhof; J de Hooge
Journal:  Am Heart J       Date:  1984-02       Impact factor: 4.749

8.  Reperfusion arrhythmia: a marker of restoration of antegrade flow during intracoronary thrombolysis for acute myocardial infarction.

Authors:  S Goldberg; A J Greenspon; P L Urban; B Muza; B Berger; P Walinsky; P R Maroko
Journal:  Am Heart J       Date:  1983-01       Impact factor: 4.749

9.  Prediction of infarct coronary artery recanalization after intravenous thrombolytic therapy.

Authors:  B J Kircher; E J Topol; W W O'Neill; B Pitt
Journal:  Am J Cardiol       Date:  1987-03-01       Impact factor: 2.778

10.  Efficacy of percutaneous transluminal coronary recanalization utilizing streptokinase thrombolysis in patients with acute myocardial infarction.

Authors:  G Lee; E A Amsterdam; R Low; J A Joye; A Kimchi; A N DeMaria; D T Mason
Journal:  Am Heart J       Date:  1981-12       Impact factor: 4.749

View more
  3 in total

1.  Non-invasive diagnosis of infarct artery patency after acute myocardial infarction by use of serial plasma troponin T concentrations: importance of measurement of peak levels.

Authors:  R M Norris; R N Johnson; H D White; D R Robinson
Journal:  Heart       Date:  1996-05       Impact factor: 5.994

Review 2.  Cardiac myofibrillar proteins: biochemical markers to estimate myocardial injury.

Authors:  K H Haider; W H Stimson
Journal:  Mol Cell Biochem       Date:  1999-04       Impact factor: 3.396

3.  Non-invasive diagnosis of arterial patency after thrombolytic treatment and its relation to prognosis.

Authors:  R M Norris; H D White; D B Cross; K S Woo; J M Elliott; D Twigden; B Williams; R N Johnson
Journal:  Br Heart J       Date:  1993-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.